Type to search

Supira Medical, a Shifamed Portfolio Company, Closes $30M in an Oversubscribed Series C Financing | Pharmtech Focus
Chroma Medicine Launches with $125M in Financing to Deliver on the Promise of Epigenetic Editing | Pharmtech Focus